ZNF189 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.712200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.023800E-01
Normal-vs-Stage2
3.377600E-01
Normal-vs-Stage3
1.998250E-01
Normal-vs-Stage4
9.965800E-01
Stage1-vs-Stage2
6.190600E-01
Stage1-vs-Stage3
4.339800E-01
Stage1-vs-Stage4
6.422000E-01
Stage2-vs-Stage3
4.954800E-01
Stage2-vs-Stage4
2.780200E-01
Stage3-vs-Stage4
2.933200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.830400E-01
Normal-vs-AfricanAmerican
6.323000E-01
Normal-vs-Asian
2.485000E-01
Caucasian-vs-AfricanAmerican
6.144400E-01
Caucasian-vs-Asian
9.267600E-01
AfricanAmerican-vs-Asian
5.778200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.041400E-01
Normal-vs-Female
4.641400E-01
Male-vs-Female
3.025200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.624700E-03
Normal-vs-Age(41-60Yrs)
7.682800E-01
Normal-vs-Age(61-80Yrs)
1.986610E-01
Normal-vs-Age(81-100Yrs)
2.206600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.244800E-04
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.346000E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.438200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.423610E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.886990E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.008200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.351200E-01
Normal-vs-Daily Drinker
5.840400E-02
Normal-vs-Weekly Drinker
4.179400E-01
Normal-vs-Occasional Drinker
1.229380E-01
Normal-vs-Social Drinker
8.576800E-01
Non Drinker-vs-Daily Drinker
2.172000E-01
Non Drinker-vs-Weekly Drinker
9.283000E-01
Non Drinker-vs-Occasional Drinker
4.698000E-01
Non Drinker-vs-Social Drinker
3.861600E-01
Daily Drinker-vs-Weekly Drinker
3.481400E-01
Daily Drinker-vs-Occasional Drinker
6.636400E-01
Daily Drinker-vs-Social Drinker
1.278550E-01
Weekly Drinker-vs-Occasional Drinker
5.808600E-01
Weekly Drinker-vs-Social Drinker
4.462400E-01
Occasional Drinker-vs-Social Drinker
2.034200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.785000E-01
Normal-vs-Grade 2
6.187900E-02
Normal-vs-Grade 3
9.518500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.530800E-01
Grade 1-vs-Grade 3
5.599400E-01
Grade 1-vs-Grade 4
1.785000E-01
Grade 2-vs-Grade 3
3.922000E-01
Grade 2-vs-Grade 4
6.187900E-02
Grade 3-vs-Grade 4
9.518500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.017630E-01
Normal-vs-NonDiabetic
3.605200E-01
Diabetic-vs-NonDiabetic
6.999800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.372630E-01
Normal-vs-NoPancreatitis
3.224400E-01
Pancreatitis-vs-NoPancreatitis
5.302000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.290000E-01
Normal-vs-N1
3.691000E-01
N0-vs-N1
9.714200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.962200E-02
Normal-vs-TP53-NonMutant
9.390800E-01
TP53-Mutant-vs-TP53-NonMutant
3.374100E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
